Membership
Advancement to Fellow of SHEA
Journal Club
SHEA Spotlight
Careers
Education & Training
SHEA LearningCE
Guidance
Compendium
Pocket Guidelines
Pocket Guidelines Digital Subscription
SHEA Guidelines Print Bundle
Resources
Antimicrobial Stewardship
BACTEC Blood Culture Vial Resources
Baxter IV Supply Chain Disruption Resources
High-Consequence Pathogens
SARS-CoV-2 Resources
Advocacy
Advocate Training & Resources
Emerging Legislation & Regulations
Priority Issues
Publications
Compendium
Podcasts
About
Board of Trustees
Committee Chairs
Strategic Plan
Diversity, Equity & Inclusion (DEI)
Guiding Principles for AI Usage
Disclosure Policy
Facebook
LinkedIn
Threads
Instagram
Bluesky
X
News
MySHEA
IDWeek
SHEA Spring
SHEA Foundation
SHEA Research Network
Donate
Join SHEA
Login
April 2023
The Costs of Inappropriate Outpatient Antibiotics
Phase 2 study of a Exeporfinium chloride (XF-73) gel, a novel agent for
S. aureus
nasal carriage reduction
Undisclosed: the role of aminopenicillins for the treatment of enterococcal UTIs despite
in vitro
resistance
Creation of a cumulative antibiogram for rapidly growing nontuberculous mycobacteria
Changing with the times: refining our mitigation strategies and policies as COVID evolves
We use cookies to help improve your experience
Ok
Enable JavaScript to ensure
website accessibility
